Adding paid at-home blood test kits to the subscription model of Hashiona - all in one platform for Hashimoto patients.

将付费家庭血液检测套件添加到 Hashiona 的订阅模式中 - 为桥本患者提供一站式平台。

• 批准号: 10047027
• 金额: $ 6.35万
• 依托单位: HASHIONA LIMITED
• 依托单位国家: 英国
• 项目类别: Grant for R&D
• 财政年份: 2022
• 资助国家: 英国
• 起止时间: 2022 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=10047027
• 关键词: Adding; paid; home; blood; test

Adding paid at-home blood test kits to the subscription model of Hashiona - all in one platform for Hashimoto and hypothyroidism patients.Hashiona is a UK-based health-tech, digital therapeutics SME with a core project team of:- Ewa Galant (Project-, Sustainability-, Inclusion/Diversity-Lead = PSID-L)- Konrad Koniarski (Technical Lead = T-L) - Miriam Mikicki, MD (Medical Lead = M-L).Hashiona is solving a significant unmet need with its innovative medical platform designed to serve people with Hashimoto's disease. The app is helping diagnosed patients to manage their thyroid condition with a science-based step-by-step programme to remission designed by clinicians and dedicated features for self-tracking, medical experts' assistance and psychological support enhanced by modern technology and patient-centric approach. The digital solution will involve all relevant groups (patients/clinicians/researchers) to effectively respond to the complexity of autoimmune disease treatment.A patient-centric approach is a way healthcare systems can establish a partnership among practitioners, patients, and their families to align decisions with patients' wants, needs, and preferences. This also includes the delivery of specific education and support patients need to make these decisions and participate in their own care. At Hashiona we promote a well-designed patient experience, which embraces the disease history of each individual patient, addresses their therapy goals, supports their hopes, and helps encourage them to follow the required protocols while engaging them in the journey and increasing adherence with clinical trials and tasks. Hashiona strives to foster a robust, supportive community around the digital solution.

Hashiona是一家总部位于英国的医疗技术和数字治疗中小企业，其核心项目团队包括：- Ewa Galant（项目-，可持续性-，包容性/多样性-负责人= PSID-L）- Konrad Koniarski（技术负责人= T-L）- Miriam Mikicki，MD（医疗负责人= M-L）。Hashiona通过其创新的医疗平台为桥本氏病患者提供服务，解决了一个重大的未满足需求。该应用程序正在帮助诊断患者管理他们的甲状腺状况，通过临床医生设计的基于科学的逐步缓解计划以及通过现代技术和以患者为中心的方法增强的自我跟踪，医学专家的帮助和心理支持的专用功能。数字解决方案将涉及所有相关群体（患者/临床医生/研究人员），以有效应对自身免疫性疾病治疗的复杂性。以患者为中心的方法是医疗保健系统可以在从业人员、患者及其家属之间建立伙伴关系的一种方式，以使决策与患者的需求、需求和偏好保持一致。这还包括提供患者做出这些决定并参与自己的护理所需的特定教育和支持。在Hashiona，我们推广精心设计的患者体验，包括每个患者的病史，解决他们的治疗目标，支持他们的希望，并帮助鼓励他们遵循所需的协议，同时让他们参与旅程并增加对临床试验和任务的依从性。Hashiona致力于围绕数字解决方案建立一个强大的支持性社区。